Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Erratum to "Thrombin generation test: A reliable tool to evaluate the pharmacodynamics of vitamin K antagonist rodenticides in rats" [Pestic. Biochem. Physiol. 146 (2018) 19-24].
Jourdi G, Lefèbvre S, Le Bonniec B, Curis E, Gaussem P, Lattard V, Siguret V. Jourdi G, et al. Among authors: siguret v. Pestic Biochem Physiol. 2018 Jul;149:149. doi: 10.1016/j.pestbp.2018.05.003. Epub 2018 May 16. Pestic Biochem Physiol. 2018. PMID: 30033011 No abstract available.
Assessment of DOAC in GEriatrics (Adage Study): Rivaroxaban/Apixaban Concentrations and Thrombin Generation Profiles in NVAF Very Elderly Patients.
Foulon-Pinto G, Lafuente-Lafuente C, Jourdi G, Guen JL, Tall F, Puymirat E, Delrue M, Rivière L, Ketz F, Gouin-Thibault I, Mullier F, Gaussem P, Pautas E, Lecompte T, Curis E, Siguret V. Foulon-Pinto G, et al. Among authors: siguret v. Thromb Haemost. 2023 Apr;123(4):402-414. doi: 10.1055/a-1981-1763. Epub 2022 Nov 17. Thromb Haemost. 2023. PMID: 36395818 Free PMC article.
Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants.
Jourdi G, Delrue M, Stepanian A, Valaize J, Foulon-Pinto G, Demagny J, Duchemin J, Nedelec-Gac F, Darnige L, Curis E, Delavenne X, Gaussem P, Siguret V, Gouin-Thibault I. Jourdi G, et al. Among authors: siguret v. Thromb Res. 2019 Dec;184:86-91. doi: 10.1016/j.thromres.2019.11.001. Epub 2019 Nov 5. Thromb Res. 2019. PMID: 31710863 Free article.
Factors Influencing Anti-Xa Assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin.
Lasne D, Toussaint-Hacquard M, Delassasseigne C, Bauters A, Flaujac C, Savard P, Mouton C, De Maistre E, Stepanian A, Eschwège V, Delrue M, Georges JL, Gros A, Mansour A, Leroy G, Jouffroy R, Mattei M, Beurton A, Pontis A, Neuwirth M, Nedelec-Gac F, Lecompte T, Curis E, Siguret V, Gouin-Thibault I. Lasne D, et al. Among authors: siguret v. Thromb Haemost. 2023 Dec;123(12):1105-1115. doi: 10.1055/s-0043-1770096. Epub 2023 Jun 15. Thromb Haemost. 2023. PMID: 37321244 Free article.
Contrast between Prevalence of HIT Antibodies and Confirmed HIT in Hospitalized COVID-19 Patients: A Prospective Study with Clinical Implications.
Delrue M, Siguret V, Neuwirth M, Brumpt C, Voicu S, Burlacu R, Sène D, Chousterman BG, Mohamedi N, Lecompte T, Mégarbane B, Stépanian A. Delrue M, et al. Among authors: siguret v. Thromb Haemost. 2021 Jul;121(7):971-975. doi: 10.1055/a-1333-4688. Epub 2021 Jan 27. Thromb Haemost. 2021. PMID: 33296940 No abstract available.
150 results